Asthma doctors say the move will put their patients at risk of life-threatening reactions when they take the drugs at home.

The FDA has approved AstraZeneca’s asthma injection, benralizumab, offering a more patient-friendly eight-week dosing regimen that could give an edge over rivals from GlaxoSmithKline and Teva.

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

For asthma in patients ≥12 years ... at least 3% of adults reported headache, injection site reactions, arthralgia, upper abdominal pain, and dizziness. At least 3% of food allergy patients ...

OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...

Sanofi has upped its revenue forecasts for the year on the back of strong second quarter results from its new eczema and asthma injection Dupixent and its rare diseases and vaccines businesses.

Blue Cross Blue Shield -- which covers more than 10 million Texans -- intends to slash coverage for several asthma therapies injected into the bloodstream under the supervision of a physician. Many ...

34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily Crossword recently. Can you solve it faster than others?

is requiring patients insured with them who have severe asthma to inject themselves with their medicine rather than asking a clinic or doctor for assistance. Patients who take injections like ...

PARAMUS, NJ - Valley Health System is proud to offer biologic injections as a treatment option for both severe asthma and chronic obstructive pulmonary disease (COPD). Biologics are monoclonal ...